Mabel Seto, PhD; Timothy J. Hohman, PhD; Elizabeth C. Mormino, PhD; et al.
JAMA Neurol. 2024;81(8):798-804. doi:10.1001/jamaneurol.2024.1763
This cross-sectional study assesses maternal history or paternal history of memory impairment (as a proxy for Alzheimer disease dementia) and brain β-amyloid burden and cognition in older adults.
Mette Foldager Hindsholm, MD; Luis Alberto García Rodríguez, MD; Axel Brandes, PhD; et al.
JAMA Neurol. 2024;81(8):805-813. doi:10.1001/jamaneurol.2024.1892
This cohort study of patients in Denmark with atrial fibrillation investigates whether discontinuation of oral anticoagulation is associated with an increased risk of recurrent ischemic stroke.
Antoine Gavoille, MD; Fabien Rollot, MSc; Romain Casey, MD; et al.
JAMA Neurol. 2024;81(8):814-823. doi:10.1001/jamaneurol.2024.1961
This cohort study evaluates clinical events identified as relapses not associated with T2 lesions or gadolinium-enhanced T1 lesions on magnetic resonance imaging.
Phuong Thuy Nguyen Ho, BSc; Sanne J. W. Hoepel, MSc; Maria Rodriguez-Ayllon, PhD; et al.
open access
JAMA Neurol. 2024;81(8):824-834. doi:10.1001/jamaneurol.2024.1755
This cohort study evaluates associations of sleep and 24-hour activity rhythms with amyloid-β deposition.
Emily K. Acton, PhD; Sean Hennessy, PharmD, PhD; Michael A. Gelfand, MD, PhD; et al.
has audio
JAMA Neurol. 2024;81(8):835-844. doi:10.1001/jamaneurol.2024.2057
This cohort study assesses rates of thromboembolic events in adults with atrial fibrillation (AF) and epilepsy receiving direct-acting oral anticoagulants (OACs) and enzyme-inducing antiseizure medications (ASMs) vs direct-acting OACs with non–enzyme-inducing ASMs.
-
Audio:
Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic Events
Colin Groot, PhD; Ruben Smith, MD, PhD; Lyduine E. Collij, PhD; et al.
open access
JAMA Neurol. 2024;81(8):845-856. doi:10.1001/jamaneurol.2024.1612
This cohort study evaluates the use of tau positron emission tomography in estimating risk of progression to dementia in individuals with mild cognitive impairment.
Gretchen L. Birbeck, MD; Karl B. Seydel, MD; Suzanna Mwanza, MMED; et al.
JAMA Neurol. 2024;81(8):857-865. doi:10.1001/jamaneurol.2024.1677
This randomized clinical trial analyzes data for children with central nervous system malaria whose fever was treated aggressively with preemptive acetaminophen and ibuprofen to assess reduction in maximum temperature vs that achieved with usual care.
Xuerong Wen, PhD, MS; Marianne N. Otoo, MPharm; Jie Tang, MD; et al.
JAMA Neurol. 2024;81(8):866-874. doi:10.1001/jamaneurol.2024.1714
This cohort study uses propensity score matching to evaluate the association of angiotensin receptor blockers use with risk of incident epilepsy compared with other antihypertensive drugs in subgroups of US patients with hypertension.
Jesse A. Columbo, MD, MS; Natalie Daya, MPH; Lisandro D. Colantonio, MD, PhD; et al.
JAMA Neurol. 2024;81(8):875-881. doi:10.1001/jamaneurol.2024.2044
This cohort study assesses the derivation and validation of International Statistical Classification of Diseases, Tenth Revision (ICD-10) codes in detecting incident stroke events in Medicare inpatient fee-for-service claims data.